Funding for this research was provided by:
U.S. Department of Veterans Affairs (1 I01 HX003549-01)
Article History
Received: 2 June 2022
Accepted: 24 February 2023
First Online: 15 March 2023
Declarations
:
: KMG and JMG report no conflicts of interest related to this topic. HBB reports research funding through his institution from BeBetter Therapeutics, Boehringer Ingelheim, Improved Patient Outcomes, Merck, NHLBI, Novo Nordisk, Otsuka, Sanofi, VA, Elton John Foundation, Hilton Foundation, and Pfizer. He also provides consulting services for Abbott, Imatar, Novartis, Sanofi, Vidya, Walmart, and Webmed. He was also on the board of directors of Preventric Diagnostics.
Free to read: This content has been made available to all.